SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001169245-23-000032
Filing Date
2023-05-19
Accepted
2023-05-19 16:18:34
Documents
1
Period of Report
2023-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_168452749044967.html 4  
1 FORM 4 wf-form4_168452749044967.xml 4 7277
  Complete submission text file 0001169245-23-000032.txt   8887
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Issuer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HATTERAS VENTURE PARTNERS III, LP 280 S. MANGUM ST., SUITE 350 DURHAM NC 27701
Business Address
Thorp Clay (Reporting) CIK: 0001592380 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38697 | Film No.: 23940346